Viemed Healthcare Inc (VMD) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown strong financial performance in its recent quarter, the technical indicators are neutral to slightly bearish, and insider selling has significantly increased. Additionally, there are no strong proprietary trading signals or positive catalysts to suggest immediate upside potential.
The MACD is negatively expanding below 0, indicating bearish momentum. RSI is neutral at 47.058, and moving averages are converging, suggesting indecision. The stock is trading near its pivot level of 9.545, with support at 9.262 and resistance at 9.828.

Strong financial performance in Q4 2025, with revenue up 25.51% YoY, net income up 30.65% YoY, and EPS up 40.00% YoY.
Insider selling has increased by 207.27% in the last month. Gross margin dropped by -2.71% YoY. No recent congress trading activity. Technical indicators are neutral to bearish.
In Q4 2025, revenue increased to $76.18M (+25.51% YoY), net income increased to $5.64M (+30.65% YoY), and EPS increased to $0.14 (+40.00% YoY). However, gross margin dropped to 57.38% (-2.71% YoY).
No recent analyst rating or price target changes available.
